Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Co-Diagnostics Inc

CODX
Current price
0.84 USD 0 USD (0.00%)
Last closed 0.83 USD
ISIN US1897631057
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 25 227 734 USD
Yield for 12 month -34.38 %
1Y
3Y
5Y
10Y
15Y
CODX
21.11.2021 - 28.11.2021

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah. Address: 2401 South Foothill Drive, Salt Lake City, UT, United States, 84109

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.50 USD

P/E ratio

Dividend Yield

Current Year

+6 812 038 USD

Last Year

+34 218 209 USD

Current Quarter

+641 141 USD

Last Quarter

+161 102 USD

Current Year

+2 627 089 USD

Last Year

+28 737 117 USD

Current Quarter

+343 738 USD

Last Quarter

-389 381 USD

Key Figures CODX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -38 666 460 USD
Operating Margin TTM -1 596.36 %
PE Ratio
Return On Assets TTM -27.61 %
PEG Ratio
Return On Equity TTM -50.57 %
Wall Street Target Price 1.50 USD
Revenue TTM 7 321 012 USD
Book Value 2.00 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -73.90 %
Dividend Yield
Gross Profit TTM 28 737 117 USD
Earnings per share -1.38 USD
Diluted Eps TTM -1.38 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 30.80 %
Profit Margin

Dividend Analytics CODX

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History CODX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CODX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 16.00
Enterprise Value Revenue 0.064
Price Sales TTM 3.45
Enterprise Value EBITDA 0.52
Price Book MRQ 0.40

Financials CODX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CODX

For 52 weeks

0.73 USD 2.23 USD
50 Day MA 1.11 USD
Shares Short Prior Month 229 088
200 Day MA 1.20 USD
Short Ratio 1.77
Shares Short 228 278
Short Percent 0.76 %